Literature DB >> 25792549

Coping strategies and behavioural changes following a genital herpes diagnosis among an urban sample of underserved Midwestern women.

Alissa Davis1, Alexis Roth2, Juanita Ebert Brand3, Gregory D Zimet4, Barbara Van Der Pol5.   

Abstract

This study focused on understanding the coping strategies and related behavioural changes of women who were recently diagnosed with herpes simplex virus type 2. In particular, we were interested in how coping strategies, condom use, and acyclovir uptake evolve over time. Twenty-eight women screening positive for herpes simplex virus type 2 were recruited through a public health STD clinic and the Indianapolis Community Court. Participants completed three semi-structured interviews with a woman researcher over a six-month period. The interviews focused on coping strategies for dealing with a diagnosis, frequency of condom use, suppressive and episodic acyclovir use, and the utilisation of herpes simplex virus type 2 support groups. Interview data were analysed using content analysis to identify and interpret concepts and themes that emerged from the interviews. Women employed a variety of coping strategies following an herpes simplex virus type 2 diagnosis. Of the women, 32% reported an increase in religious activities, 20% of women reported an increase in substance use, and 56% of women reported engaging in other coping activities. A total of 80% of women reported abstaining from sex immediately following the diagnosis, but 76% of women reported engaging in sex again by the six-month interview. Condom and medication use did not increase and herpes simplex virus type 2 support groups were not utilised by participants. All participants reported engaging in at least one coping mechanism after receiving their diagnosis. A positive diagnosis did not seem to result in increased use of condoms for the majority of participants and the use of acyclovir was low overall.
© The Author(s) 2015.

Entities:  

Keywords:  HSV-2; Herpes simplex virus; acyclovir use; behaviour; condoms; genital herpes; sexual; sexually transmitted infection; treatment; viral disease; women

Mesh:

Substances:

Year:  2015        PMID: 25792549      PMCID: PMC5008844          DOI: 10.1177/0956462415578955

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  21 in total

1.  Herpes simplex virus type 2 in the United States, 1976 to 1994.

Authors:  D T Fleming; G M McQuillan; R E Johnson; A J Nahmias; S O Aral; F K Lee; M E St Louis
Journal:  N Engl J Med       Date:  1997-10-16       Impact factor: 91.245

2.  Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis.

Authors:  Anna Wald; Katherine Link
Journal:  J Infect Dis       Date:  2001-12-14       Impact factor: 5.226

3.  Court-based participatory research: collaborating with the justice system to enhance sexual health services for vulnerable women in the United States.

Authors:  Alexis Roth; J Dennis Fortenberry; Barbara Van Der Pol; Joshua Rosenberger; Brian Dodge; Janet Arno; Janine Waters; David Certo; Michael Reece
Journal:  Sex Health       Date:  2012-11       Impact factor: 2.706

4.  The relationship between condom use and herpes simplex virus acquisition.

Authors:  Anna Wald; Andria G M Langenberg; Elizabeth Krantz; John M Douglas; H Hunter Handsfield; Richard P DiCarlo; Adaora A Adimora; Allen E Izu; Rhoda Ashley Morrow; Lawrence Corey
Journal:  Ann Intern Med       Date:  2005-11-15       Impact factor: 25.391

5.  Factors predicting the acceptance of herpes simplex virus type 2 antibody testing among adolescents and young adults.

Authors:  Gregory D Zimet; Susan L Rosenthal; J Dennis Fortenberry; Rebecca C Brady; Wanzhu Tu; Jingwei Wu; David I Bernstein; Lawrence R Stanberry; Katherine M Stone; Jami S Leichliter; Kenneth H Fife
Journal:  Sex Transm Dis       Date:  2004-11       Impact factor: 2.830

Review 6.  Herpes simplex virus type 2 serological testing and psychosocial harm: a systematic review.

Authors:  Kaile Ross; Christine Johnston; Anna Wald
Journal:  Sex Transm Infect       Date:  2011-09-08       Impact factor: 3.519

7.  Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States.

Authors:  Fujie Xu; Maya R Sternberg; Benny J Kottiri; Geraldine M McQuillan; Francis K Lee; Andre J Nahmias; Stuart M Berman; Lauri E Markowitz
Journal:  JAMA       Date:  2006-08-23       Impact factor: 56.272

8.  A pooled analysis of the effect of condoms in preventing HSV-2 acquisition.

Authors:  Emily T Martin; Elizabeth Krantz; Sami L Gottlieb; Amalia S Magaret; Andria Langenberg; Lawrence Stanberry; Mary Kamb; Anna Wald
Journal:  Arch Intern Med       Date:  2009-07-13

9.  Serologic screening for herpes simplex virus among university students: a pilot study.

Authors:  Hayley Mark; Joy P Nanda; Alain Joffe; Jessica Roberts; Anne Rompalo; Johan Melendez; Jonathan Zenilman
Journal:  J Am Coll Health       Date:  2008 Nov-Dec

10.  Prevalent herpes simplex virus type 2 infection is associated with altered vaginal flora and an increased susceptibility to multiple sexually transmitted infections.

Authors:  Rupert Kaul; Nico J Nagelkerke; Joshua Kimani; Elizabeth Ngugi; Job J Bwayo; Kelly S Macdonald; Anu Rebbaprgada; Karolien Fonck; Marleen Temmerman; Allan R Ronald; Stephen Moses
Journal:  J Infect Dis       Date:  2007-10-25       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.